Aasha S. Gopal

Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods.

BACKGROUND Reliable, serial, noninvasive quantitative estimation of left ventricular ejection fraction is essential for selecting and timing therapeutic interventions in patients with heart disease. Equilibrium radionuclide angiography is widely used for this purpose but has well-recognized limitations. Advantages of echocardiography over equilibrium radionuclide angiography include assessment of wall motion, valvular pathology, and cardiac hemodynamics, in addition to portability, lack of radiation exposure, and substantially lower cost. However, conventional echocardiographic techniques are limited by geometric assumptions, image positioning errors, and use of subjective visual methods. To overcome these limitations, a three-dimensional echocardiographic method was developed. This study compares ejection fraction by three-dimensional echocardiography, quantitative two-dimensional echocardiography, and subjective two-dimensional echocardiographic visual estimation with that by equilibrium radionuclide angiography. METHODS AND RESULTS Fifty-one unselected patients with suspected heart disease underwent left ventricular ejection fraction determination by equilibrium radionuclide angiography and three-dimensional echocardiography using an interactive line-of-intersection display and a new algorithm, ventricular surface reconstruction, for volume computation. In 44 patients, ejection fractions were also estimated visually by experienced observers from two-dimensional echocardiography and by quantitative two-dimensional echocardiography using an apical biplane summation-of-disks algorithm. An excellent correlation was obtained between three-dimensional echocardiography and equilibrium radionuclide angiography (r = .94 to .97, SEE = 3.64% to 5.35%; limits of agreement, 10.3% to 13.3%) without significant underestimation or overestimation. SEE values and limits of agreement were twofold to threefold lower than corresponding values for all two-dimensional echocardiographic techniques. In addition, interobserver variability was significantly lower for the three-dimensional echocardiographic method (10.2%) than for the apical biplane summation-of-disks method (26.1%) and subjective visual estimation (33.3%). CONCLUSIONS Determination of ejection fraction by three-dimensional echocardiography yields results comparable to those obtained by equilibrium radionuclide angiography and is substantially superior to all two-dimensional echocardiographic methods. Therefore, three-dimensional echocardiography may be used for accurate serial quantification of left ventricular function as an alternative to equilibrium radionuclide angiography.

Left ventricular volume and endocardial surface area by three-dimensional echocardiography: Comparison with two-dimensional echocardiography and nuclear magnetic resonance imaging in normal subjects☆

OBJECTIVES We evaluated a three-dimensional echocardiographic method for ventricular volume and surface area determination that uses polyhedral surface reconstruction. Six to eight nonparallel, unequally spaced, nonintersecting short-axis planes were positioned with a line of intersection display to overcome limitations associated with two-dimensional echocardiography. BACKGROUND Two-dimensional echocardiographic methods of ventricular volume and surface area determination are limited by assumptions about ventricular shape and image plane position. METHODS Left ventricular end-diastolic and end-systolic volumes and endocardial surface areas determined by three-dimensional echocardiography and nuclear magnetic resonance (NMR) imaging were compared in 15 normal subjects (7 men, 8 women, aged 23 to 41 years, body surface area 1.38 to 2.17 m2). Ten of these subjects also underwent two-dimensional echocardiography; and end-diastolic and end-systolic volumes were determined by the apical biplane summation of discs method and compared with results of NMR imaging. RESULTS Interobserver variability was 5% to 8% for three-dimensional echocardiography and 6% to 9% for NMR imaging. Both methods were in close agreement on end-diastolic volume (r = 0.92, SEE = 6.99 ml) and end-systolic volume (r = 0.81, SEE = 4.01 ml) and on end-diastolic surface area (r = 0.84, SEE = 8.25 cm2) and end-systolic surface area (r = 0.84, SEE = 4.89 cm2). Three-dimensional echocardiography and NMR imaging correlated significantly better for end-diastolic volume (r = 0.90, SEE = 7.0 ml) and end-systolic volume (r = 0.88, SEE = 3.1 ml) than did two-dimensional echocardiography and NMR imaging (r = 0.48, SEE = 20.5 ml for end-diastolic volume; r = 0.70, SEE = 5.6 ml for end-systolic volume). CONCLUSIONS Three-dimensional echocardiography is an in vivo method of measuring left ventricular end-diastolic and end-systolic volumes and endocardial surface area with results comparable to those of NMR imaging. Additionally, three-dimensional echocardiography is superior to the two-dimensional echocardiographic apical biplane summation method because the technique eliminates geometric assumptions and image plane positioning error.

Three-dimensional Echocardiographic Volume Computation by Polyhedral Surface Reconstruction: In Vitro Validation and Comparison to Magnetic Resonance Imaging

Two-dimensional echocardiographic methods of left ventricular volume computation are limited by geometric assumptions and image plane positioning error in the nonvisualized dimension. We evaluated a three-dimensional (3D echocardiographic method that addresses these limitations. Our method uses a volume computation algorithm based on polyhedral surface reconstruction (PSR) and nonparallel, unequally spaced, nonintersecting short-axis planes. Seventeen balloon phantoms were subjected to volume computation by the 3D echocardiography-PSR method and by magnetic resonance imaging (MRI) and compared to true volumes determined by water displacement. The results for 3D echocardiography-PSR were: accuracy = 2.27%, interobserver variability = 4.33%, r = 0.999, SEE = 2.45 ml, and p less than 0.001. Results for MRI were 8.01%, 13.78%, r = 0.995, SEE = 7.01 ml, and p less than 0.001. There was no statistically significant difference between the methods. We conclude that precise image plane positioning and use of the 3D echocardiographic-PSR volume computation method achieves high accuracy and reproducibility in vitro. The excellent in vitro correlation between 3D echocardiography-PSR and MRI indicates that MRI may also serve as an in vivo standard of comparison.

Comparison of two- and three-dimensional echocardiography with cineventriculography for measurement of left ventricular volume in patients

OBJECTIVES We compared two- and three-dimensional echocardiography with cineventriculography for measurement of left ventricular volume in patients. BACKGROUND Three-dimensional echocardiography has been shown to be highly accurate and superior to two-dimensional echocardiography in measuring left ventricular volume in vitro. However, there has been little comparison of the two methods in patients. METHODS Two- and three-dimensional echocardiography were performed in 35 patients (mean age 48 years) 1 to 3 h before left ventricular cineventriculography. Three-dimensional echocardiography used an acoustic spatial locator to register image position. Volume was computed using a polyhedral surface reconstruction algorithm based on multiple nonparallel, unevenly spaced short-axis cross sections. Two-dimensional echocardiography used the apical biplane summation of disks method. Single-plane cineventriculographic volumes were calculated using the summation of disks algorithm. The methods were compared by linear regression and a limits of agreement analysis. For the latter, systematic error was assessed by the mean of the differences (cineventriculography minus echocardiography), and the limits of agreement were defined as +/- 2 SD from the mean difference. RESULTS Three-dimensional echocardiographic volumes demonstrated excellent correlation (end-diastole r = 0.97; end-systole r = 0.98) with cineventriculography. Standard errors of the estimate were approximately half of those of two-dimensional echocardiography (end-diastole +/- 11.0 ml vs. +/- 21.5 ml; end-systole +/- 10.2 ml vs. +/- 17.0 ml). By limits of agreement analysis the end-diastolic mean differences for two- and three-dimensional echocardiography were 21.1 and 12.9 ml, respectively. The limits of agreement (+/- 2 SD) were +/- 54.0 and +/- 24.8 ml, respectively. For end-systole, comparable improvement was obtained by three-dimensional echocardiography. Results for ejection fraction by the two methods were similar. CONCLUSIONS Three-dimensional echocardiography correlates highly with cineventriculography for estimation of ventricular volumes in patients and has approximately half the variability of two-dimensional echocardiography for these measurements. On the basis of this study, three-dimensional echocardiography is the preferred echocardiographic technique for measurement of ventricular volume. Three-dimensional echocardiography is equivalent to two-dimensional echocardiography for measuring ejection fraction.

Three-dimensional echocardiography: In vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods

OBJECTIVES This study aimed to validate a method for mass computation in vitro and in vivo and to compare it with conventional methods. BACKGROUND Conventional echocardiographic methods of determining left ventricular mass are limited by assumptions of ventricular geometry and image plane positioning. To improve accuracy, we developed a three-dimensional echocardiographic method that uses nonparallel, nonintersecting short-axis planes and a polyhedral surface reconstruction algorithm for mass computation. METHODS Eleven fixed hearts were imaged by three-dimensional echocardiography, and mass was determined in vitro by multiplying the myocardial volume by the density of each heart and comparing it with the true mass. Mass at diastole and systole by three-dimensional echocardiography and magnetic resonance imaging (MRI) was compared in vivo in 15 normal subjects. Ten subjects also underwent imaging by one- and two-dimensional echocardiography, and mass was determined by Penn convention, area-length and truncated ellipsoid algorithms. RESULTS In vitro results were r = 0.995, SEE 2.91 g, accuracy 3.47%. In vivo interobserver variability for systole and diastole was 16.7% to 27%, 14% to 18.1% and 6.3% to 12.8%, respectively, for one-, two- and three-dimensional echocardiography and was 7.5% for MRI at end-diastole. The latter two agreed closely with regard to diastolic mass (r = 0.895, SEE 11.1 g) and systolic mass (r = 0.926, SEE 9.2 g). These results were significantly better than correlations between MRI and the Penn convention (r = 0.725, SEE 25.6 g for diastole; r = 0.788, SEE 28.7 g for systole), area-length (r = 0.694, SEE 24.2 g for diastole; r = 0.717, SEE 28.2 g for systole) and truncated ellipsoid algorithms (r = 0.687, SEE 21.8 g for diastole; r = 0.710, SEE 24.5 g for systole). CONCLUSIONS Image plane positioning guidance and elimination of geometric assumptions by three-dimensional echocardiography achieve high accuracy for left ventricular mass determination in vitro. It is associated with higher correlations and lower standard errors than conventional methods in vivo.

Ultrasound Beam Orientation During Standard Two-dimensional Imaging: Assessment by Three-dimensional Echocardiography

Standard two-dimensional echocardiographic image planes are defined by anatomic landmarks and assumptions regarding their orientation when these landmarks are visualized. However, variations of anatomy and technique may invalidate these assumptions and thus limit reproducibility and accuracy of cardiac dimensions recorded from these views. To overcome this problem, we have developed a three-dimensional echocardiograph consisting of a real-time scanner, three-dimensional spatial locater, and personal computer. This system displays the line of intersection of a real-time image and an orthogonal reference image and may be used to assess actual image orientation during standardized two-dimensional imaging when the line-of-intersection display is not observed by the operator. Three hundred forty standard images were assessed from 85 examinations by 11 echocardiographers. Twenty-four percent of the unguided standard images were optimally positioned within +/- 5 mm and +/- 15 degrees of the standard. Of the optimal images, two thirds were parasternal long-axis views. A subsequent study with three-dimensional echocardiography and line-of-intersection guidance of image positioning showed 80% of the guided images to be optimally positioned, a threefold improvement (p < 0.001). Two-dimensional echocardiography does not achieve reasonably consistent optimal positioning of standard imaging views, suggesting that measurements taken from these views are likely to be suboptimal. Three-dimensional echocardiography that uses line-of-intersection guidance improves image positioning threefold and should therefore improve the accuracy and reproducibility of quantitative echocardiographic measurements derived from these images.

Relative Importance of Errors in Left Ventricular Quantitation by Two-Dimensional Echocardiography: Insights From Three-Dimensional Echocardiography and Cardiac Magnetic Resonance Imaging

BACKGROUND The accuracy of left ventricular (LV) volumes and ejection fraction (EF) on two-dimensional echocardiography (2DE) is limited by image position (IP), geometric assumption (GA), and boundary tracing (BT) errors. METHODS Real-time three-dimensional echocardiography (RT3DE) and cardiac magnetic resonance imaging (CMR) were used to determine the relative contribution of each error source in normal controls (n = 35) and patients with myocardial infarctions (MIs) (n = 34). LV volumes and EFs were calculated using (1) apical biplane disk summation on 2DE (IP + GA + BT errors), (2) biplane disk summation on RT3DE (GA + BT errors), (3) 4-multiplane to 8-multiplane surface approximation on RT3DE (GA + BT errors), (4) voxel-based surface approximation on RT3DE (BT error alone) and (5) CMR. By comparing each method with CMR, the absolute and relative contributions of each error source were determined. RESULTS IP error predominated in LV volume quantification on 2DE in normal controls, whereas GA error predominated in patients with MIs. Underestimation of volumes on 2DE was overcome by increasing the number of imaging planes on RT3DE. Although 4 equidistant image planes were acceptable, the best results were achieved with voxel-based RT3DE. For EF estimation, IP error predominated in normal controls, whereas BT error predominated in patients with MIs. Nevertheless, one third of the EF estimation error in patients with MIs was due to a combination of IP and GA errors, both of which may be addressed using RT3DE. CONCLUSIONS The relative contribution of each source of LV quantitation error on 2DE was defined and quantified. Each source of error differed depending on patient characteristics and LV geometry.

Three-Dimensional Echocardiography Compared to Two-Dimensional Echocardiography for Measurement of Left Ventricular Mass Anatomic Validation in an open chest Canine Model

A three-dimensional echocardiographic system has been developed that can accurately compute left ventricular mass in vitro. This study was designed to validate the new echocardiographic system for the measurement of left ventricular mass in vivo and to compare the accuracy of three-dimensional echocardiography to the accuracy of conventional two-dimensional echocardiography for measuring left ventricular mass. Echocardiographic imaging was performed 6 h following coronary ligation in 20 open chest dogs, at which time the heart was excised and the left ventricle weighed. Three-dimensional echocardiography used multiple short axis sections and polyhedral surface reconstruction to compute myocardial volume. The two dimensional methods employed the truncated ellipsoid model and the area-length model. Myocardial volume was multiplied by 1.05 g/cc and echocardiographic mass estimates were compared to the true left ventricular weight. Three-dimensional echocardiography provided the best correlation (r = 0.96, upsilon r = 0.88 and r = 0.83 for the truncated-ellipsoid and area-length methods, respectively), and the lowest standard error of the estimate for the regression equation (+/- 5.5 g upsilon +/- 11.0 and +/- 14.6 g, respectively). Three dimensional echocardiography also had the lowest standard deviation for the echo-true mass differences (+/- 5.8 g upsilon +/- 10.7 g and +/- 14.2 g) and a lower root mean square percent error (6.8%) upsilon 12.6% and 12.7%). In this open chest canine model, three-dimensional echocardiography is more accurate than standard two-dimensional echocardiographic methods for measuring left ventricular mass.

Value of Two-Dimensional Speckle Tracking and Real Time Three-Dimensional Echocardiography for the Identification of Subclinical Left Ventricular Dysfunction in Patients Referred for Routine Echocardiography

Background: While speckle tracking echocardiography (2DSTE) can be used to study longitudinal, circumferential, and radial function, real time 3D echocardiography (3DE) generates dynamic time–volume curves, offering a wide array of new parameters for characterizing mechanical and volumetric properties of the left ventricle (LV). Our aim was to investigate the merit of these new techniques to separate normal from abnormal echocardiograms as well as to identify subclinical disease in reportedly normal subjects. Methods: Eighty‐one patients (mean age 61 ± 16 years) underwent standard 2D echocardiography (2DE) enhanced by 2DSTE and 3DE. The data included LV volumes and ejection fraction (EF), velocities, strain/strain rate, and peak ejection/filling rates. The patients were divided into Group 1: normal (n = 42) and Group 2: abnormal (n = 39) on the basis of an expert interpretation of the resting 2DE. Results: Global longitudinal strain (%) was 17 ± 4 in Group1 and 14 ± 4 in Group2 (P < 0.002). Strain rates (SR, 1/sec) at peak systole (1.1 ± 0.2 vs 0.9 ± 0.3, P < 0.001) and early diastole (1.3 ± 0.3 vs 0.9 ± 0.3, P < 0.001) were also higher in Group1. Three‐dimensional peak ejection and filling rates (EDV/sec) were significantly higher in Group1 (−2.5 ± 0.4 vs −2.1 ± 0.7, and 1.8 ± 0.2 vs 1.5 ± 0.5, P < 0.002, P < 0.001, respectively). The best discriminatory power for predicting a normal 2DE was systolic SR with a sensitivity of 82% and a specificity of 54% using a cutoff value of 1.09. Interestingly, 19/41 (46%) of Group1 patients had systolic SR < 1.09, suggesting subclinical disease. Conclusions: 2DSTE and 3DE can discriminate between normal and abnormal echocardiograms and have the potential to detect subclinical LV dysfunction.

Validation of three-dimensional echocardiography for quantifying the extent of dyssynergy in canine acute myocardial infarction: Comparison with two-dimensional echocardiography

OBJECTIVES This study was designed to compare the accuracy of three- and two-dimensional echocardiography for quantifying the extent of abnormal wall motion in experimental acute myocardial infarction, as correlated with the pathologic determination of infarct size. BACKGROUND Two-dimensional echocardiographic estimations of the fraction of myocardium showing abnormal wall motion are often used as an index of infarct size even though they rely on image plane positioning and geometric assumptions that may not be valid. Three-dimensional echocardiographic reconstruction of the endocardial surface eliminates the need for these assumptions and may improve echocardiographic estimates of infarct size. METHODS Coronary ligation was performed in 14 open chest dogs, and echocardiographic imaging of the ventricle was performed 6 h later. Three-dimensional echocardiography used seven or eight spatially registered short-axis images to measure percent of endocardial surface and mass showing abnormal wall motion. Three two-dimensional echocardiographic methods using multiple, nonpatially registered images were evaluated. One method used seven or eight-axis slices and a summation of discs algorithm for computing surface area. The second method used the same images and a conical model for the left ventricle. The third used basal, middle and apical short-axis plus apical four- and two-chamber views comparing summed endocardial lengths showing abnormal wall motion with the total of the endocardial dimensions, expressed as percent. The percent of left ventricular mass and surface area infarcted was determined by staining with triphenyltetrazolium chloride. RESULTS Three-dimensional echocardiographic measurements of endocardial surface and correlated more closely with infarct mass (r = 0.94, SEE +/- 3.6%) than did the two-dimensional method using the summation of discs algorithm (r = 0.85, SEE +/- 6.6%), he summation of conical sections algorithm (r = 0.82, SEE +/- 5.4%) or the method using summed endocardial lengths (r = 0.79, SEE +/- 7.4%). Limits of agreement analysis comparing mass showing abnormal wall motion with anatomic infarct mass surface area showing abnormal wall motion with anatomic infarct surface area showed the smallest limits for three-dimensional echocardiography. CONCLUSIONS Three-dimensional echocardiography is a more accurate means of noninvasively estimating myocardial infarct size in this canine model than two-dimensional echocardiography.